INTERNATIONAL PATENT: NUCLIDIUM AG, UNIVERSITY OF BASEL FILES APPLICATION FOR "SOMATOSTATIN RECEPTOR-TARGETING RADIOPHARMACEUTICALS AND USES THEREOF"

GENEVA, Oct. 1 -- NUCLIDIUM AG (IM Erasmushaus, Baumleingasse 18CH-4051 Basel), UNIVERSITY OF BASEL (Vizerektorat ForschungPetersgraben 35CH-4001 Basel) filed a patent application (PCT/US2025/021199) for "SOMATOSTATIN RECEPTOR-TARGETING RADIOPHARMACEUTICALS AND USES THEREOF" on Mar 24, 2025. With publication no. WO/2025/199541, the details related to the patent application was published on Sep 25, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): JAAFAR-THIEL, Leila (IM Erasmushaus, Baumleingasse 18CH-4051 Basel), DE ROSE, Francesco (IM Erasmushaus, Baumleingasse 18CH-4051 Basel), FANI, Melpom...